Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Trends: Abbott Laboratories Insider Sale for Taxes Adds to 90-Day Selling Trend

06/07/2021 | 05:36pm EDT


ę MT Newswires 2021
All news about ABBOTT LABORATORIES
08/03INSIDER TRENDS : Insider at Abbott Laboratories Makes Shares Sale for Tax Slowin..
MT
08/03ABBOTT LABORATORIES : Secures FDA Clearance for Ultreon Software-Powered Optical..
MT
08/03ABBOTT : Receives FDA Clearance for its Imaging Technology Using Artificial Inte..
PR
08/03Abbott Gets FDA Approval for AI-Powered Imaging Tech
DJ
08/02Abbott Labs to pay $160 million over kickbacks, false diabetes claims to Medi..
RE
08/02Abbott's FreeStyle« Libre 2 iOS App Cleared in U.S., Providing a Seamless Dig..
CI
07/30ABBOTT LABORATORIES : - half of americans living with diabetes may be consuming ..
AQ
07/29NEW STUDY : Half of Americans Living with Diabetes May be Consuming Less Than th..
PR
07/27Global markets live: LVMH, Michelin, Tesla, Amazon, Activision...
07/23ABBOTT LABORATORIES : Jefferies & Co Adjusts Abbott Laboratories PT to $135 From..
MT
More news
Financials (USD)
Sales 2021 39 766 M - -
Net income 2021 5 967 M - -
Net Debt 2021 8 719 M - -
P/E ratio 2021 36,4x
Yield 2021 1,40%
Capitalization 217 B 217 B -
EV / Sales 2021 5,68x
EV / Sales 2022 5,63x
Nbr of Employees 109 000
Free-Float 89,0%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | MarketScreener
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 122,12 $
Average target price 128,81 $
Spread / Average Target 5,48%
EPS Revisions
Managers and Directors
Robert B. Ford President, CEO, Chief Operating Officer & Director
Robert Emmett Funck Chief Financial Officer & Executive Vice President
Miles D. White Executive Chairman
Sabina Ewing Chief Investment Officer, VP-Business & Technology
Roxanne Schuh Austin Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ABBOTT LABORATORIES10.44%216 985
MEDTRONIC PLC12.05%176 670
BECTON, DICKINSON AND COMPANY2.22%74 383
HOYA CORPORATION15.49%55 510
ALIGN TECHNOLOGY, INC.31.24%55 502
SARTORIUS STEDIM BIOTECH65.93%52 806